Newman Ferrara LLP Announces Corporate Governance Investigation of CME Group Inc. – CME
January 31 2022 - 4:08PM
Business Wire
Newman Ferrara LLP announced today that the firm is conducting
an investigation on behalf of shareholders of CME Group Inc. (“CME”
or the “Company”) (NASDAQ:CME) into potential breaches of fiduciary
duty by the Company’s Board of Directors (the “Board”).
CME, headquartered in Chicago, IL, operates contract markets for
the trading of futures and options on futures contracts worldwide.
Newman Ferrara’s investigation focuses on decisions made by the
Board, without shareholder approval, the result of which
significantly diminish shareholder value and do not benefit the
Company.
Current CME stockholders seeking more information on this matter
are invited to contact Newman Ferrara attorneys Jeffrey Norton
(jnorton@nfllp.com) or Benjamin Baker (bbaker@nfllp.com) to discuss
this investigation and their rights.
Newman Ferrara maintains a multifaceted practice based in New
York City with attorneys specializing in complex commercial and
multi-party litigation, securities fraud and shareholder
litigation, consumer protection, civil rights, and real estate. For
more information, please visit the firm website at
www.nfllp.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220131005929/en/
Newman Ferrara LLP Jeffrey M. Norton jnorton@nfllp.com 1250
Broadway, 27th Fl. New York, NY 10001 (212) 619-5400
CME (NASDAQ:CME)
Historical Stock Chart
From Jun 2024 to Jul 2024
CME (NASDAQ:CME)
Historical Stock Chart
From Jul 2023 to Jul 2024